BENDA Program

Bio-electronic Neuro-Phrostetic Devices for Active Regeneration post CNS injuries

Find out more


The World’s Lightest and Smartest “Wear-and-Forget” Companion Device for Ambient Assisted Living

Find out more


In complex neurological diseases, such as multiple sclerosis, stroke or spinal cord injuries, a treatment with stem cells may be the sole remaining choice of cure

Find out more


To provide innovation in high-tech fields/high-growth sectors requiring multi-disciplinary approaches and know-how.
from bio-electronics, smart sensors and systems to advanced solutions for nano-medicine, cell-therapies, and drug delivery.


Our vision is to innovate within both the health care and medical fields by repositioning state of the art technologies in order to improve people’s quality of life and cost of care.


We provide research & development expertise and hands-on experience to support feasibility studies and business innovation.

We work with an experienced team of designers and expert engineers, medical advisors, biologists, material scientists and project managers, allocated as technical staff to each project. This allows an effective and sustainable way to achieve the project goals timely and with the right focus.

We work with third parties in a foundry-based manufacturing scheme to scale-up the products into the global market.

View More



CITC Ltd partner with Zinergy at IDTechEx conference to introduce its new Patch4Life™ platform to the public for the first time.

Berlin - Germany, 12th April 2018 - The IDTechEx Conference (emerging technologies unleashed) in Berlin yesterday, saw CEO of Zinergy, Dr Pritesh Hiralal discuss the future of printed, flexible energy storage and its application in healthcare patches with specific reference to CITC’s Patch4life™ and the technology used within.

Over the last 9 months CITC Ltd and Zinergy have been developing the world’s lightest and smartest “Wear-and-Forget”Companion Device for Ambient Assisted Living. This thin, comfortable and lightweight patch is designed for use in both hospitals and at home for 24/7 personalised health and environmental monitoring. 

Read More

Personalised stem cell treatment to provide relief to people with progressive MS

Cambridge, 22nd February 2017 - Scientists within the Department of Clinical Neurosciences at Cambridge University with close links with CITC Ltd. have demonstrated the ability to directly re-programme skin cells into brain stem cells that when transplanted into the central nervous system help reduce inflammation and may help repair the damaged tissue caused by multiple sclerosis.

This study - performed in mice and published online today in the journal Cell Stem Cell – is a major step towards the development of personalised stem cell treatment based on using a patient’s own skin cells to treat chronic illnesses of the CNS. Advances in stem cell biology have raised great expectations that diseases of the central nervous system (CNS) may be improved by the development of stem cell therapies.

Read More

RNA nanotherapeutics to inhibit neurotoxic glial responses

Cambridge, December 2017 - Research conducted by CITC Ltd scientists in conjunction with the Department of Clinical Neurosciences and Stem Cell Institute at Cambridge University demonstrates that RNA nanotherapeutics curtail the production of an inflammation-spreading signal released by cells of the central nervous system (CNS) in response to injury or disease.

Read More

CITC Ltd. appoints a new Research Associate and Project Manager

Cambridge, December 2017 - Dr. Smith, an expertly trained Chemist and Computer scientist, as well as pRNA nanotechnologist, has begun his involvement in the CUPIDO project, which aims at developing Cardio Ultrefficient nanoParticles for Inhalation of Drug prOducts.

Read More

© Copyright 2018 Cambridge Innovation Technologies Consulting LtdWeb Design By Toolkit Websites